

A complete guide to Afinitor drug interactions. Learn which medications, supplements, and foods to avoid and what to tell your doctor.
Afinitor (Everolimus) is processed by your liver through a system called CYP3A4 — the same system that handles a long list of other medications, supplements, and even certain foods. When another substance speeds up or slows down this system, it changes how much Afinitor ends up in your bloodstream. Too much can increase side effects. Too little can make the drug less effective against your cancer or condition.
That's why understanding Afinitor's drug interactions isn't optional — it's essential for your safety and treatment success. This guide covers the major and moderate interactions, supplements to watch, food and drink concerns, and exactly what to tell your doctor.
Afinitor is metabolized primarily by the CYP3A4 enzyme in your liver. It's also a substrate of a transporter called P-glycoprotein (PgP). Interactions happen in two main ways:
Think of CYP3A4 like a drain. Inhibitors clog the drain (drug levels rise). Inducers widen it (drug levels drop). Either way, the carefully calibrated dose your doctor prescribed gets thrown off.
These medications have significant interactions with Afinitor and should be avoided or require your doctor to adjust your Afinitor dose:
Strong CYP3A4 inhibitors (increase Afinitor levels significantly):
If you need one of these medications, your doctor may cut your Afinitor dose in half or more — or switch you to a non-interacting alternative.
Strong CYP3A4 inducers (decrease Afinitor levels significantly):
These drugs can make Afinitor much less effective. Your doctor may double the Afinitor dose or, ideally, switch you to a non-interacting alternative.
Live vaccines:
These medications may interact with Afinitor and require monitoring or dose adjustments:
Moderate CYP3A4 inhibitors:
With moderate inhibitors, your doctor may reduce your Afinitor dose to prevent side effects from elevated drug levels.
ACE inhibitors (increased risk of angioedema):
Taking Afinitor with ACE inhibitors significantly raises the risk of angioedema — sudden, serious swelling of the face, lips, tongue, or throat. This is a medical emergency. If you take an ACE inhibitor for blood pressure, your doctor may switch you to a different type of blood pressure medication.
P-glycoprotein (PgP) inhibitors and substrates may also affect Afinitor levels. Discuss any PgP-related medications with your oncologist.
It's not just prescription drugs — common supplements and OTC products can also interact with Afinitor:
As a general rule, tell your doctor about every supplement you take — even if it seems harmless. Many herbal products affect the CYP3A4 system.
What you eat and drink can also affect how Afinitor works:
Regular oranges, lemons, and limes are fine. The interaction is specific to grapefruit, Seville oranges, and starfruit.
Before your first dose, give your doctor a complete picture of everything you take and any health conditions you have:
Your oncologist or pharmacist can cross-check your medications against Afinitor's interaction profile. Don't assume something is safe just because it's over-the-counter or "natural."
Afinitor has significant drug interactions — especially with CYP3A4 inhibitors, CYP3A4 inducers, ACE inhibitors, grapefruit, and St. John's Wort. The good news is that most interactions are well-documented and manageable when your doctor knows about them. The most important thing you can do is be completely transparent about every medication, supplement, and food habit.
For more about Afinitor, explore our guides on side effects, uses and dosing, and saving money on your prescription. And if you need help finding Afinitor at a pharmacy, Medfinder can help.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.